Position in CABA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,789,567
+$12,445,737 QoQ
Shares Held
4,112,401
+8631.2% QoQ
Ownership
2.43%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 139 holders
Holding Since
Mar 2020
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CABA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. CABA ranks #38 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in CABA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,789,567 | 4,112,401 | Shares | Sole | 2026-08-12 | |
| 2026-06-30 | $27,292,280 | 8,775,653 | Shares | Sole | 2026-08-12 | |
| 2020-03-31 | $343,830 | 47,100 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||